Geometric tumor embolic budding characterizes inflammatory breast cancer Arnav P. ModiJulie P. T. NguyenSanford H. Barsky Preclinical Study 06 December 2022 Pages: 461 - 478
Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer Byung-Hee KangBum-Sup JangIn Ah Kim Preclinical Study 14 December 2022 Pages: 479 - 488
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study Binghe XuTao SunZhimin Shao Clinical trial Open access 02 December 2022 Pages: 489 - 501
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): final analysis of a phase III, randomized, double-blind, placebo-controlled study Binghe XuWei LiAdam Knott Clinical trial Open access 04 December 2022 Pages: 503 - 513
Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer Yu LiuYing WangZaiyi Liu Clinical trial 13 December 2022 Pages: 515 - 523
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial Jiahui HuangYiwei TongKunwei Shen Clinical Trial 16 December 2022 Pages: 525 - 533
Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing W. Iris ZhiRaymond E. BaserTing Bao Clinical Trial 17 December 2022 Pages: 535 - 545
Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer Shoshana M. RosenbergYue ZhengAnn H. Partridge Epidemiology 27 November 2022 Pages: 547 - 558
Textbook outcomes in DIEP flap breast reconstruction: a Delphi study to establish consensus Ronnie L. ShammasGeoffroy C. SiskBrett T. Phillips Epidemiology 28 November 2022 Pages: 559 - 568
Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up Song-lin GaoDing-yuan WangPeng Yuan Epidemiology 05 December 2022 Pages: 569 - 582
Ovarian removal and subsequent breast cancer prognosis: a nationwide cohort study Mathilde GottschauSusanne K. KjærLene Mellemkjær Epidemiology 08 December 2022 Pages: 583 - 591
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer Akihiko ShimomuraMasayuki YoshidaAkihiko Suto Epidemiology Open access 09 December 2022 Pages: 593 - 602
Relationship between tamoxifen and cataracts: a nationwide cohort study of women in South Korea Chang Ik YoonHye Sun LeeWoo-Chan Park Epidemiology 10 December 2022 Pages: 603 - 612
Risk factors for reduced function in women with a history of breast cancer Nicholas StoylesAndrea ChevilleSean R. Smith Epidemiology 10 December 2022 Pages: 613 - 621
Changes in the survival of patients with breast cancer: Poland, 2000–2019 Florentino Luciano Caetano dos SantosIrmina Maria MichalekJoanna Didkowska Epidemiology Open access 12 December 2022 Pages: 623 - 631
Exploring the intersectionality of race/ethnicity with rurality on breast cancer outcomes: SEER analysis, 2000–2016 Justin Xavier MooreSydney Elizabeth AndrzejakYunan Han Epidemiology Open access 15 December 2022 Pages: 633 - 645
The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa Oluwatosin A. AyeniShingirai ChiwambutsaAlfred I. Neugut Epidemiology 20 December 2022 Pages: 647 - 659
Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study Hiroyuki OhbeTsuyoshi Hachiyafor the Japan Public Health Center-based Prospective Study Group Epidemiology 20 December 2022 Pages: 661 - 671
Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer Jeffrey FranksNicole E. CastonGabrielle B. Rocque Epidemiology Open access 21 December 2022 Pages: 673 - 681
Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network Hayeon KimHong WangMargaret Q. Rosenzweig Original Laboratory Investigation Open access 17 December 2022 Pages: 683 - 692